| 1 | [SID24822998] | Active | Potency | 4.2284 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 4.2284 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 2 | [SID24822998] | Active | Potency | 4.2284 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 4.2284 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 3 | [SID24822998] | Active | Potency | 4.2284 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 4.2284 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 4 | [SID24822998] | Active | Potency | 4.2284 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 4.2284 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 5 | [SID24822998] | Active | Potency | 5.8048 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 5.8048 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID24822998] | Active | Potency | 7.9433 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 7 | [SID24822998] | Active | Potency | 10 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 8 | [SID24822998] | Active | Potency | 10 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 9 | [SID24822998] | Active | Potency | 10 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 10 | [SID24822998] | Active | EC50 | 10.4 | Dose response confirmation of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay [AID489024, Type: confirmatory] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | EC50 | 10.4 [uM] | | BioAssay | Dose response confirmation of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay | | AID | 489024 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID24822998] | Active | Potency | 11.2202 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 12 | [SID24822998] | Active | Potency | 11.2202 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 13 | [SID24822998] | Active | Potency | 11.2202 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 14 | [SID24822998] | Active | Potency | 11.2202 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 15 | [SID24822998] | Active | Potency | 11.2202 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 16 | [SID24822998] | Active | Potency | 11.2202 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 17 | [SID24822998] | Active | Potency | 11.5821 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID24822998] | Active | Potency | 14.1254 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 19 | [SID24822998] | Active | Potency | 14.1254 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 20 | [SID24822998] | Active | Potency | 14.581 | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 21 | [SID24822998] | Active | Potency | 17.7828 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 22 | [SID24822998] | Active | Potency | 25.1189 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 23 | [SID24822998] | Active | Potency | 25.1189 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 24 | [SID24822998] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4) [AID463165, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4) | | AID | 463165 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 25 | [SID24822998] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4) [AID463165, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4) | | AID | 463165 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 26 | [SID24822998] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4) [AID463165, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4) | | AID | 463165 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 27 | [SID24822998] | Active | | | Validation assay for identification of compounds that inhibit the regulator of G-protein signaling 4 (RGS4) [AID492999, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | BioAssay | Validation assay for identification of compounds that inhibit the regulator of G-protein signaling 4 (RGS4) | | AID | 492999 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 28 | [SID24822998] | Active | | | Validation assay for identification of compounds that inhibit the regulator of G-protein signaling 4 (RGS4) [AID492999, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | BioAssay | Validation assay for identification of compounds that inhibit the regulator of G-protein signaling 4 (RGS4) | | AID | 492999 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 29 | [SID24822998] | Active | | | Validation assay for identification of compounds that inhibit the regulator of G-protein signaling 4 (RGS4) [AID492999, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | BioAssay | Validation assay for identification of compounds that inhibit the regulator of G-protein signaling 4 (RGS4) | | AID | 492999 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 30 | [SID24822998] | Active | | | Second counter screen for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4): Non-induced cells with the primary screen assay without carbachol activation [AID493001, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | BioAssay | Second counter screen for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4): Non-induced cells with the primary screen assay without carbachol activation | | AID | 493001 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 31 | [SID24822998] | Active | | | Second counter screen for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4): Non-induced cells with the primary screen assay without carbachol activation [AID493001, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | BioAssay | Second counter screen for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4): Non-induced cells with the primary screen assay without carbachol activation | | AID | 493001 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 32 | [SID24822998] | Active | | | Second counter screen for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4): Non-induced cells with the primary screen assay without carbachol activation [AID493001, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | BioAssay | Second counter screen for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4): Non-induced cells with the primary screen assay without carbachol activation | | AID | 493001 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 33 | [SID24822998] | Active | | | HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress [AID2732, Type: screening] | Ddit3 gene product [Mus musculus] [gi:160707929] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | BioAssay | HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress | | AID | 2732 | | BioAssay type | screening | | Target | Ddit3 gene product [Mus musculus] [gi:160707929] | | PubMed | | | Data Table |  |
|
| 34 | [SID24822998] | Active | | | HTS assay for identification of inhibitors of TNF-a-specific NF-kB induction [AID1852, Type: other] | TNF gene product [Homo sapiens] [gi:25952111] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | BioAssay | HTS assay for identification of inhibitors of TNF-a-specific NF-kB induction | | AID | 1852 | | BioAssay type | other | | Target | TNF gene product [Homo sapiens] [gi:25952111] | | PubMed | | | Data Table |  |
|
| 35 | [SID24822998] | Active | | | HTS assay for identification of inhibitors of TNF-a-specific NF-kB induction [AID1852, Type: other] | TNF gene product [Homo sapiens] [gi:25952111] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | BioAssay | HTS assay for identification of inhibitors of TNF-a-specific NF-kB induction | | AID | 1852 | | BioAssay type | other | | Target | TNF gene product [Homo sapiens] [gi:25952111] | | PubMed | | | Data Table |  |
|
| 36 | [SID24822998] | Active | | | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin [AID2314, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | BioAssay | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin | | AID | 2314 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 37 | [SID24822998] | Active | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN. [AID2023, Type: screening] | LAP4 [Saccharomyces cerevisiae] [gi:486173] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN. | | AID | 2023 | | BioAssay type | screening | | Target | LAP4 [Saccharomyces cerevisiae] [gi:486173] | | PubMed | | | Data Table |  |
|
| 38 | [SID24822998] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12) [AID652126, Type: screening] | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12) | | AID | 652126 | | BioAssay type | screening | | Target | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] | | PubMed | | | Data Table |  |
|
| 39 | [SID24822998] | Active | | | Single concentration confirmation of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay [AID463112, Type: screening] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | BioAssay | Single concentration confirmation of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay | | AID | 463112 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID24822998] | Active | | | 384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC [AID463187, Type: screening] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | BioAssay | 384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC | | AID | 463187 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID24822998] | Active | | | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity [AID651661, Type: screening] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651661 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID24822998] | Active | | | uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay [AID449763, Type: screening] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | BioAssay | uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay | | AID | 449763 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID24822998] | Active | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD1 [AID1578, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD1 | | AID | 1578 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 44 | [SID24822998] | Active | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD1 [AID1578, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD1 | | AID | 1578 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 45 | [SID24822998] | Active | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 46 | [SID24822998] | Active | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 47 | [SID24822998] | Active | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 48 | [SID24822998] | Active | | | Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A) [AID588511, Type: screening] | Ano1 gene product [Mus musculus] [gi:334278898] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A) | | AID | 588511 | | BioAssay type | screening | | Target | Ano1 gene product [Mus musculus] [gi:334278898] | | PubMed | | | Data Table |  |
|
| 49 | [SID24822998] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 50 | [SID24822998] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 24822998 | | CID | 2201779 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|